Deva Holding A.S. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended Sep, 30, 2017
November 01, 2017
Share
Deva Holding A.S. announced unaudited consolidated earnings results for the second quarter and six months ended Sep, 30, 2017. For the quarter, revenue was TRY 178,605,282 compared to TRY 145,587,077 a year ago. Operating profit was TRY 31,300,361 compared to TRY 24,284,995 a year ago. Profit before taxation was TRY 16,904,615 compared to TRY 12,223,213 a year ago. Net profit for the period was TRY 19,477,916 compared to TRY 11,074,529 a year ago. Diluted profit per share was TRY 0.0010 compared to TRY 0.0006 a year ago.
For the six months, revenue was TRY 597,722,030 compared to TRY 515,789,429 a year ago. Operating profit was TRY 106,219,927 compared to TRY 98,881,316 a year ago. Profit before taxation was TRY 62,356,704 compared to TRY 61,875,010 a year ago. Net profit for the period was TRY 59,997,068 compared to TRY 52,960,848 a year ago. Diluted profit per share was TRY 0.0030 compared to TRY 0.0026 a year ago. Cash flows used in operations activities was TRY 157,628,158 compared to TRY 167,310,100 a year ago. Purchase of Property, Plant and Equipment was TRY 40,918,218 compared to TRY 35,723,304 a year ago. Purchase of Intangible Assets was TRY 50,348,739 compared to TRY 34,794,986 a year ago.
Deva Holding AS is a Turkey-based pharmaceutical company that is primarily engaged in the production and marketing of finished pharmaceutical products, pharmaceutical ingredients and veterinary products, as well as animal health products, among others. The Company has four production facilities in Turkey. Its production facilities include the Tokapi, Cerezkoy I, Cerezkoy II and Kartepe production plants. The Companyâs product portfolio comprises 73 drugs, which are available on the market in 177 various forms. It offers products, such as Azitro, Alemax, Cefax, Inhibace, Imatis, Hydrea, Kardozin, Kristapen, Magcar, Magnesie Calcinee, Nostil, Oceral, Remidon, Prolixin and Quet, among others. The Company has two subsidiaries, namely Vetaa Veteriner ve Tarim Ilaclari A.S. and Deva Holding NZ Ltd.